Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Dyne Therapeutics, Inc. | Director | Common Stock | 901K | $42.3M | $47.01 | Aug 21, 2024 | Indirect |
Dyne Therapeutics, Inc. | Director | Stock option (right to buy) | 25.1K | May 22, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
DYN | Dyne Therapeutics, Inc. | Aug 20, 2024 | 5 | -$10.4M | 4 | Aug 22, 2024 | Director |
DYN | Dyne Therapeutics, Inc. | Aug 16, 2024 | 6 | -$11.3M | 4 | Aug 20, 2024 | Director |
DYN | Dyne Therapeutics, Inc. | Aug 14, 2024 | 3 | -$12.6M | 4 | Aug 16, 2024 | Director |
DYN | Dyne Therapeutics, Inc. | Aug 12, 2024 | 5 | -$9.12M | 4 | Aug 14, 2024 | Director |
DYN | Dyne Therapeutics, Inc. | Aug 8, 2024 | 6 | -$7.88M | 4/A | Aug 14, 2024 | Director |
DYN | Dyne Therapeutics, Inc. | Aug 8, 2024 | 6 | -$7.88M | 4 | Aug 12, 2024 | Director |
DYN | Dyne Therapeutics, Inc. | May 22, 2024 | 1 | $0 | 4 | May 24, 2024 | Director |
DYN | Dyne Therapeutics, Inc. | Jan 9, 2024 | 2 | $30M | 4 | Jan 11, 2024 | Director, 10%+ Owner |
DYN | Dyne Therapeutics, Inc. | May 24, 2023 | 1 | $0 | 4 | May 25, 2023 | Director, 10%+ Owner |
DYN | Dyne Therapeutics, Inc. | Jun 3, 2022 | 1 | $0 | 4 | Jun 6, 2022 | Director, 10%+ Owner |
DYN | Dyne Therapeutics, Inc. | May 26, 2021 | 1 | $0 | 4 | May 27, 2021 | Director, 10%+ Owner |